# Novel Immune Markers in Patients With Multiple Sclerosis

> **NCT01026272** · — · UNKNOWN · sponsor: **University of Washington** · enrollment: 120 (estimated)

## Conditions studied

- Multiple Sclerosis

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01026272
- **Lead sponsor:** University of Washington
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2010-01
- **Primary completion:** 2011-01
- **Final completion:** 2011-05
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2010-07-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01026272

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01026272, "Novel Immune Markers in Patients With Multiple Sclerosis". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT01026272. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*